In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-12 of 12 for your search:
Drug:  leflunomide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.035, CDR0000067275, SUGEN-990711, NCT00004071

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.015, CDR0000066226, MSKCC-98020, UCLA-HSPC-980105201, NCT00003293

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.004, NCI-V96-1091

4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-088, NCT01611675

5.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.009, NYU-9828

6.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.010

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.021, CDR0000066904, MSKCC-98111, NCI-G99-1506, NCT00003775

8.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-95019, NCI-V95-0663

9.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.002, NCI-V96-1090

10.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.003, NCI-V96-1092

11.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 3 to 21
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NCI-97-C-0087E, SUGEN-NCI-97-C-0087

12.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-HSPC-980901101B, SUGEN-SU101.032A, NCI-G99-1550
New Search